about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersFinding all BRCA pathogenic mutation carriers: best practice modelsOpportunities for immunotherapy in microsatellite instable colorectal cancerThe genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discoveryA germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancerNTHL1 defines novel cancer syndromeGrowth hormone normalizes hepatic lipase in hypothyroid rat liverRare mutations in XRCC2 increase the risk of breast cancerCardiovascular risk of BRCA1/2 mutation carriers: A review.Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impactA simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients.Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trialCommon genetic variants and modification of penetrance of BRCA2-associated breast cancerBRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration.Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age.Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial.Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients.Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress.Mapping of constitutional translocation breakpoints in renal cell cancer patients: identification of KCNIP4 as a candidate gene.Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014.A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationChromosome 3 translocations and the risk to develop renal cell cancer: a Dutch intergroup study.Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
P50
Q21144874-B4FE56BC-DE0F-4FE3-B352-DE2E16889A69Q26741854-339A0D2A-6C43-49BF-A5AF-DB80ED04A622Q28066110-439D7625-6E44-4F85-869E-00C377AA8C39Q28077234-4FBE5E92-9E86-4090-AF2A-62F46B1EC34CQ28261506-A41EA047-2071-4A05-A57B-11D5B5784FC6Q28268029-07F669CA-B702-4037-9EC6-C2D1BE65A085Q28573291-E88BDF61-825A-46C5-AB61-D60D9F329018Q28730692-D4A6FCF0-0D42-46FC-90EE-FAAF180F4235Q30248813-FEA45A2E-601F-41E4-926E-2BC97E96FA2BQ30458477-2CCF8EE3-05AF-420F-8015-EA1B9FEC8E59Q30652890-EA9F2FA3-FAC9-4230-A1E1-AB5FEEBA004CQ33247548-D3989EB1-AA67-4AF6-B2B2-3BF0AF30280DQ33260860-4B5B2E29-2A62-453C-8B11-F8F3F64F79FCQ33296082-1252CDD0-5DA0-4D88-B087-096179693CD4Q33423923-E8CD1B2F-1311-4FEF-A283-2FF9D7CCDCABQ33475933-E4804E77-8820-435F-AA0B-6F60D3B56FC9Q33648552-C1B1AE33-20E6-489A-A295-F303492E029AQ33705546-2C4669F9-433A-4233-A8D3-59A1AC62EAFFQ33742096-433A9184-E991-47B8-8AFB-4B7409847FA8Q33747361-F1C8D9D4-1DA5-4196-B948-BA8407B24CC5Q33751637-0F836870-8173-4F61-80E8-00306BE7734EQ33885464-C008DE88-5695-4695-BD62-F0B52729C23FQ33892091-A638063A-C138-43F1-8EA7-C56E692EC565Q34001845-196EC516-A7FC-49E1-BB88-A46E396A3B14Q34153211-4AC42720-8B28-4983-945A-F8872048194EQ34252077-6AEC80A4-FE51-4D1C-8CE8-802E5F5A2DA4Q34255048-739F10BC-73E2-4845-B7A9-097F5903723DQ34262449-9AF1D947-DC44-4C28-90B6-6FF2571A903CQ34325613-25F277A6-FE20-4524-B0A9-9F6036D00C31Q34346668-1E42CCB3-DFF6-470F-AAD4-E3E40184B70CQ34394665-AA2AFC82-CC27-4EAB-841C-C28B3B457A3BQ34565199-C61D5517-96AE-4984-B9F1-A67FD052FF56Q34709106-BC86AA4A-4BC4-4B71-8A2F-80CFABA5ABCFQ34788325-62341D9C-E0CF-48F6-A2A3-58E63BF5F5A2Q34949394-DD89AD75-9BAC-4359-9692-FE3099F896C3Q34963894-51E603DC-16AB-4999-A614-F0DE9F530BABQ35002552-6ACEA9D7-B10F-49D7-BB25-895956551E3DQ35089479-2B691B0B-AD96-4178-9E30-629FD9D6E068Q35181981-E648B17A-42A0-4ABA-9573-5DF8C3BDFEE6Q35375343-83751D5B-70DE-4C41-8134-85402FBFE2A3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicoline Hoogerbrugge
@ast
Nicoline Hoogerbrugge
@en
Nicoline Hoogerbrugge
@es
Nicoline Hoogerbrugge
@nl
type
label
Nicoline Hoogerbrugge
@ast
Nicoline Hoogerbrugge
@en
Nicoline Hoogerbrugge
@es
Nicoline Hoogerbrugge
@nl
altLabel
Hoogerbrugge, N
@en
prefLabel
Nicoline Hoogerbrugge
@ast
Nicoline Hoogerbrugge
@en
Nicoline Hoogerbrugge
@es
Nicoline Hoogerbrugge
@nl
P1053
O-1016-2013
P106
P31
P496
0000-0003-2393-8141